GENETICS : PANAKEIA CBG
TYPE : Indica Hybrid
FLOWERING : 8 Weeks
PANAKEIA CBG
“Panakeia”, the first THC-free (0.00%) cannabis strain with a high CBG content (18%), arrives in the USA. Panakeia seeds and clones, developed by Hemp Trading, (sold by Gnomes Seeds), specializing in the breeding of high-quality hemp and CBD seeds, and Front Range Biosciences, a technology provider for the breeding and production of new varieties of hemp, coffee and regulated cannabis plants and seeds.
Panakeia effectively breaks the legal barrier of “hot cannabis”. In the US, hot cannabis is any strain that exceeds 0.3% THC and is therefore illegal. On the contrary, Panakeia is completely free of psychoactive components (0.00% total THC) and eliminates the associated vulnerabilities during harvest and subsequent commercialization: no legal obstacles and no risk throughout the chain.
Currently, farmers are forced to destroy hemp crops when they exceed the THC levels allowed by federal law, and hemp processors face legal challenges due to concentration during extraction. Panakeia solves these problems.
The potential of Panakeia lies not only in its 0.00% THC, but also in its high concentration of cannabigerol (CBG) up to 18%. CBG is a cannabinoid that has been present in residual form in the hemp plant until now and provides significant health benefits, according to various studies. Studies suggest that CBG may have beneficial effects in relieving pain, glaucoma, or psoriasis; it may also have anti-inflammatory and antibacterial properties.
CBG CONCENTRATION: 18%
THC CONCENTRATION: 0%
STRUCTURE: Indica Dominance
HEIGHT: 120-200cm
PRODUCTION: High
MEDICAL VALUE: Glaucoma, psoriasis, pain reliever, anti-inflammatory, antibacterial.
